Connection
Udaya Kompella to Molecular Targeted Therapy
This is a "connection" page, showing publications Udaya Kompella has written about Molecular Targeted Therapy.
|
|
Connection Strength |
|
 |
|
 |
|
0.157 |
|
|
|
-
Thakur A, Scheinman RI, Rao VR, Kompella UB. Pazopanib, a multitargeted tyrosine kinase inhibitor, reduces diabetic retinal vascular leukostasis and leakage. Microvasc Res. 2011 Nov; 82(3):346-50.
Score: 0.079
-
Durazo SA, Kadam RS, Drechsel D, Patel M, Kompella UB. Brain mitochondrial drug delivery: influence of drug physicochemical properties. Pharm Res. 2011 Nov; 28(11):2833-47.
Score: 0.078